market access

Market Access

Part Two: Navigating the complexities of global market acces...

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Market Access

Part One: Overcoming challenges and seizing opportunities in...

The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked condi

Market Access

Applying intercultural intelligence to promote growth in the...

There are significant opportunities for pharma and biotech companies to support patients in the Middle East, but how do companies navigate such a culturally diverse region?

News

Germany inches closer to confidential pricing for drugs

Pharma companies who want to keep the prices of their medicines private in Germany may soon be able to do so – as long as they meet certain conditions.

Market Access

Encouraging early engagement to revitalise Europe’s pharmace...

In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’

Market Access

Managing the challenges and embracing the opportunities of E...

The way HTAs are conducted in Europe is changing. And, if organisations act now to overcome the challenges, they could reap the rewards for years to come.

Part Two: Navigating the complexities of global market acces...

Part One: Overcoming challenges and seizing opportunities in...

Applying intercultural intelligence to promote growth in the...

Germany inches closer to confidential pricing for drugs

Encouraging early engagement to revitalise Europe’s pharmace...

Managing the challenges and embracing the opportunities of E...

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks